| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |